Patient monitoring during drug administration

• US 20070010756A1
• Filed: 07/07/2005
• Published: 01/11/2007
• Est. Priority Date: 07/07/2005
• Status: Abandoned Application

• Current Assignee: General Electric Company
• Original Assignee: General Electric Company
• Inventors: Viertio-Oja, Hanna
• Application Number:
  US11/176,945
• Publication Number:
  US 20070010756A1
• Time in Patent Office: Days
• US Class Current: 600/544
• CPC Class Codes: A61B 5/374 Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
• CPC Class Codes: A61B 5/4821 Determining level or depth of anaesthesia A61B5/1106 takes precedence
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders
• CPC Class Codes: G16Z 99/00 Subject matter not provided for in other main groups of this subclass

Abstract

The invention relates to a method and apparatus for monitoring a patient during drug administration. In the monitoring process, at least one state index indicative of the clinical state of the patient is determined based on physiological signal data obtained from the patient. In order to eliminate inconsistencies caused by varying drug combinations in the at least one state index, drug administration data is maintained, which identifies the drug(s) administered to the patient, and the determination of the at least one state index is controlled in dependence on the drug administration data, thereby to produce values for the at least one state index, which remain substantially consistent regardless of the particular combination of the drugs administered to the patient.

Claims

1. A method for monitoring a patient, the method comprising the steps of:

administering at least one drug to a patient;

maintaining drug administration data that identifies the at least one drug administered in the administering step;

obtaining physiological signal data from the patient;

based on the physiological signal data, determining at least one state index indicative of a clinical state of the patient; and

controlling the determining step in dependence on the drug administration data, thereby to produce values for the at least one state index, which remain substantially consistent regardless of the at least one drug administered to the patient.

2. A method according to claim 1, wherein the controlling step includes controlling the determining step dynamically in dependence on the drug administration data, whereby the values remain substantially consistent regardless of the at least one drug administered to the patient at each time.

3. A method according to claim 2, wherein

the obtaining step includes obtaining EEG signal data from the patient;

and

the determining step includes determining the at least one state index, in which the at least one state index is indicative of the hypnotic level existing in the patient.

4. A method according to claim 3, wherein determining step includes determining the irregularity of the EEG signal data.

5. A method according to claim 3, wherein determining step includes determining the spectral entropy of the EEG signal data.

6. A method according to claim 3, wherein the determining step includes determining a bispectral value based on a bispectral analysis.

7. A method according to claim 2, wherein the controlling step includes a step of correcting the at least one state index in dependence on the drug administration data.

8. A method according to claim 1, wherein the controlling step includes a step of changing at least one parameter value used for determining the at least one state index in the determining step, wherein the changing step is performed in dependence on the drug administration data.

9. A method according to claim 7, wherein the correcting step includes the sub-steps of defining a correction transform based on the drug administration data and applying the correction transform to the at least one state index.

10. A method according to claim 9, wherein

the administering step includes administering an opioid to the patient;

the maintaining step includes maintaining drug administration data,

in which the drug administration data further indicates the amount of the opioid administered in the administering step; and

the defining sub-step includes defining the correction transform based on the opioid and the amount indicated by the drug administration data.

11. A method according to claim 8, wherein the changing step includes changing at least one frequency range used in the determining step.

12. A method according to claim 7, wherein the determining step includes determining the at least one state index, in which the at least one state index is indicative of the patient'"'"'s level of nociception.

13. An apparatus for monitoring a patient, the apparatus comprising:

means for receiving drug administration data that identifies at least one drug administered to a patient;

monitoring means for determining, based on physiological signal data obtained from the patient, at least one state index indicative of a clinical state of the patient; and

control means for controlling the monitoring means in dependence on the drug administration data, thereby to produce values for the at least one state index, which remain substantially consistent regardless of the at least one drug administered to the patient.

14. An apparatus according to claim 13, wherein the control means are configured to control the monitoring means dynamically in dependence on the drug administration data, whereby the values remain substantially consistent regardless of the at least one drug administered to the patient at each time.

15. An apparatus according to claim 14, wherein the monitoring means are configured to receive EEG signal data from the patient and to determine, based on the EEG signal data, at least one state index indicative of the hypnotic level existing in the patient.

16. An apparatus according to claim 15, wherein the monitoring means are configured to determine the irregularity of the EEG signal data.

17. An apparatus according to claim 16, wherein the monitoring means are configured to determine the spectral entropy of the EEG signal data.

18. An apparatus according to claim 15, wherein the monitoring means are configured to determine a bispectral value based on a bispectral analysis.

19. An apparatus according to claim 14, wherein control means are configured to correct the at least one state index in dependence on the drug administration data.

20. An apparatus according to claim 13, wherein control means are configured to change at least one parameter in dependence on the drug administration data, and wherein the at least one parameter is used by the monitoring means for determining the at least state index.

21. An apparatus according to claim 19, wherein the control means are further configured to define a correction transform based on the drug administration data and apply the correction transform to the at least one state index.

22. An apparatus according to claim 21, wherein

the drug administration data indicates the amount of an opioid administered to the patient;

and

the control means are further configured to define the correction transform based on the opioid and the amount.

23. An apparatus according to claim 20, wherein control means are configured to change at least one frequency range in dependence on the drug administration data, the at least one frequency range being used by the monitoring means for determining the at least state index.

24. An apparatus according to claim 13, further comprising drug delivery means for delivering the at least one drug to the patient, the drug delivery means being configured to produce the drug administration data.

25. An apparatus for monitoring a patient, the apparatus comprising:

a first controller configured to receive drug administration data that identifies at least one drug administered to a patient;

a computing unit configured to determine, based on physiological signal data obtained from the patient, at least one state index indicative of a clinical state of the patient; and

a third controller configured to control the computing unit in dependence on the drug administration data, thereby to produce values for the at least one state index, which remain substantially consistent regardless of the at least one drug administered to the patient.

26. A computer program product for an apparatus monitoring a patient, the computer product comprising:

a first program code portion configured to receive drug administration data which identifies at least one drug administered to a patient; and

a second program code portion configured to control a monitoring process adapted to calculate at least one state index indicative of a clinical state of the patient, wherein the second program code portion is configured to control the monitoring process in dependence on the drug administration data thereby to eliminate drug-dependent inconsistencies in the at least one state index.